Spyre Therapeutics, Inc.
SYRE
$14.67
$0.543.82%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 77.76% | 103.45% | 81.00% | 1,159.53% | 508.99% |
| Total Receivables | -- | 942.94% | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 139.27% | 135.57% | 237.99% | -52.72% | -63.53% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 78.16% | 104.46% | 81.64% | 998.08% | 448.57% |
|
|
|||||
| Total Current Assets | 78.16% | 104.46% | 81.64% | 998.08% | 448.57% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -96.98% | -99.24% | -75.06% | -76.30% | -79.80% |
| Total Assets | 77.99% | 103.16% | 79.06% | 829.60% | 380.52% |
|
|
|||||
| Total Accounts Payable | -25.67% | 207.81% | 13.21% | 50.63% | 32.35% |
| Total Accrued Expenses | -6.49% | -5.59% | -66.54% | 295.50% | 127.78% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 1,288.92% | 36.31% | -95.17% | 345.78% | 263.25% |
| Total Other Current Liabilities | 1,288.92% | 36.31% | -95.17% | 345.78% | 263.25% |
| Total Current Liabilities | 69.05% | 28.23% | -90.47% | 238.83% | 118.19% |
|
|
|||||
| Total Current Liabilities | 69.05% | 28.23% | -90.47% | 238.83% | 118.19% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -70.91% | 74.77% | 85.37% | 12,395.30% | 5,676.27% |
| Total Liabilities | -42.55% | 42.92% | -75.68% | 1,683.59% | 657.44% |
|
|
|||||
| Common Stock & APIC | 74.82% | 138.23% | 134.98% | 62.44% | 60.34% |
| Retained Earnings | -27.21% | -30.65% | -28.13% | -82.02% | -79.60% |
| Treasury Stock & Other | -40.40% | 1,203.79% | -5,127.27% | -5,950.00% | 729.17% |
| Total Common Equity | 39,834.80% | 169.91% | 205.40% | -197.05% | -101.81% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -15.74% | -59.75% | -21.03% | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -15.74% | -59.75% | -21.03% | -- | -- |
|
|
|||||
| Total Common Equity | 39,834.80% | 169.91% | 205.40% | -197.05% | -101.81% |
| Total Preferred Equity | -15.74% | -59.75% | -21.03% | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 181.39% | 131.04% | 3,826.71% | 352.48% | 265.80% |
|
|
|||||